New FDA commissioner Stephen Hahn outlined his agenda for the agency in an all-hands email yesterday.
A radiation oncologist, Hahn took over as FDA chief in December after a stint as chief medical officer at Houston’s M.D. Anderson Cancer Center. In the email, Hahn focused on three areas: better acquisition, integration and use of data; patient- and consumer-empowerment; and innovation, choice and competition.
Get the full story on our sister site, Medical Design & Outsourcing.